European Organisation For Research And Treatment Of Cancer - Eortc
Clinical trials sponsored by European Organisation For Research And Treatment Of Cancer - Eortc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a pill replace chemo for older breast cancer patients? Results expected Sep 2026 (estimated)
- Scientists launch global study to unlock secrets of male breast cancer Results expected Dec 2026 (estimated)
- New hope for tough brain tumors: targeted radiation trial launches Results expected Apr 2027 (estimated)
- Could chemo before surgery beat sarcoma? new trial aims to find out Results expected Apr 2027 (estimated)
- New combo therapy aims to slow head and neck cancer spread Results expected Jul 2027 (estimated)
-
Brain mets showdown: radiation plus new combo drug tested in lung cancer
Disease control Not yet recruitingThis study tests two treatment plans for people with lung cancer that has spread to the brain but is not causing major symptoms. One group gets focused radiation to all brain tumors first, then a new immunotherapy drug (ivonescimab) plus chemotherapy. The other group gets the imm…
Phase 2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New combo aims to outdo standard chemo for FLT3-Mutated leukemia
Disease control Not yet recruitingThis study tests a new three-drug combination (gilteritinib, azacitidine, and venetoclax) against standard chemotherapy for adults with a specific genetic subtype of acute myeloid leukemia (FLT3-ITD). About 230 newly diagnosed patients aged 18-75 who are healthy enough for intens…
Phase 2/3 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can a smartwatch track how cancer treatment affects daily life?
Knowledge-focused Not yet recruitingThis study explores whether cancer patients undergoing treatment can use a smartwatch and smartphone surveys to report their quality of life and physical activity. Over 12 weeks, participants wear a smartwatch at least 10 hours a day and complete questionnaires at several time po…
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC